Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, December 20, 2013 NEW YORK, December 20, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Tenet Healthcare Corp. (NYSE: THC), Rockwell Medical Inc. (NASDAQ: RMTI), Magellan Health Services Inc. (NASDAQ: MGLN), and HealthSouth Corp. (NYSE: HLS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Pfizer Inc. Research Report On December 17, 2013, Pfizer Inc. (Pfizer) announced that the Company has settled its litigation against Teva Pharmaceuticals, USA Inc. (Teva) regarding Pfizer's patent covering the use of Viagra to treat erectile dysfunction (sildenafil citrate 25, 50, and 100 mg tablets) which expires in April 2020 (including pediatric exclusivity). Pfizer reported that Teva will be allowed to launch a generic version of Viagra in the US on December 11, 2017 or earlier under certain circumstances, as a result of the settlement. Further, Pfizer informed that Teva will pay the Company a royalty for a license to produce Viagra's generic version. The Full Research Report on Pfizer Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/d702_PFE Tenet Healthcare Corp. Research Report On December 17, 2013, Tenet Healthcare Corp.'s (Tenet) stock declined 1.85%, ending the day at $39.86. Over the previous three trading sessions, shares of Tenet declined 1.39%, compared to the S&P 500 which gained 0.31% during the same period. The Full Research Report on Tenet Healthcare Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/1d25_THC Rockwell Medical Inc. Research Report On December 17, 2013, Rockwell Medical Inc.'s (Rockwell Medical) stock declined 19.82%, ending the day at $10.80. Over the previous three trading sessions, shares of Rockwell Medical declined 20.47%, compared to the Nasdaq Composite which gained 0.63% during the same period. The Full Research Report on Rockwell Medical Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/3079_RMTI Magellan Health Services Inc. Research Report On December 17, 2013, Magellan Health Services Inc. (Magellan Health Services) announced that for full-year 2014, the Company expects to generate net revenue in the range of $3.6 billion to $3.8 billion, and net income in the range of $57 million to $73 million or $2.00 to $2.56 per diluted share, inclusive of share repurchases to date and the effect of the Affordable Care Act (ACA) tax. In addition, Magellan Health Services reported that it expects segment profit for full-year 2014 to be in the range of $215 million to $235 million. Jon N. Rubin, Chief Financial Officer of Magellan Health Services, said, "The next year will be a transitional year for us. By the end of 2014, we anticipate a more stable customer base from which we can achieve earnings growth in future years, with significant contributions from our Magellan Complete Care and Magellan Pharmacy Solutions businesses. Beyond 2014, we are optimistic about our future, targeting a long-term compound annual growth rate in both revenue and earnings per share of 20 percent." The Full Research Report on Magellan Health Services Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/4b85_MGLN HealthSouth Corp. Research Report On December 17, 2013, HealthSouth Corp. (HealthSouth) announced that the Company will take part in the 32^nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2014 to January 16, 2014. The Company added that HealthSouth President and CEO, Jay Grinney, is scheduled to speak on January 14, 2014 at 10:30 a.m. PT/1:30 p.m. ET. The Company added that interested parties may listen to live webcast by visiting HealthSouth's Investor Relations website and clicking on an available link. The Full Research Report on HealthSouth Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/9080_HLS EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. http://www.AnalystsCorner.com SOURCE Analysts' Corner Contact: Joe Thomas, +1-310-496-8071 (North America)
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan
Press spacebar to pause and continue. Press esc to stop.